US2003148372A1PendingUtilityA1
Method to screen phage display libraries with different ligands
Priority: Oct 20, 1997Filed: Oct 1, 2001Published: Aug 7, 2003
Est. expiryOct 20, 2017(expired)· nominal 20-yr term from priority
C12N 15/1037C07K 16/00C07K 1/047C07K 14/7051G01N 33/6854C07K 16/005C07K 14/705C07K 2317/21C07K 14/70503C07K 2317/622G01N 33/6845C40B 40/02C40B 30/04
57
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to methods for selecting repertoires of polypeptides using generic and target ligands. In particular, the invention relates to a library wherein the folded members have binding sites for both generic and target ligands.
Claims
exact text as granted — not AI-modified1 . A library wherein the folded members have binding sites for both generic and target ligands.
2 . A library designed for selection with both generic and target ligands.
3 . The library according to claim 1 or claim 2 comprising a repertoire of polypeptides of the immunoglobulin superfamily.
4 . The library according to claim 3 wherein the polypeptides are antibody or T-cell receptor polypeptides.
5 . The library according to claim 4 , wherein the polypeptides are V H or V β domains.
6 . The library according to claim 4 , wherein the polypeptides are V L or V α domains.
7 . The library wherein a repertoire of polypeptides according to claim 5 and a repertoire of polypeptides according to claim 6 are contacted with generic ligands and the subsets thereby obtained are then pooled.
8 . The library according to claim 1 , wherein the polypeptides are varied at random positions.
9 . The library according to claim 1 , wherein the polypeptides are varied at selected positions.
10 . The library according to claim 9 , wherein the selected positions are those which form the binding site for the target ligand.
11 . The library according to claim 10 , wherein the selected positions are a subset of those which form the binding site for the target ligand.
12 . The library wherein a repertoire of polypeptides according to claim 11 is first contacted with a target ligand in order to isolate a subset of polypeptides specific for the target ligand, the subset of polypeptides then being varied at a further subset of residues in order to modify the function, specificity or affinity of target ligand interaction.
13 . The library according to any one of claims 9 - 12 , wherein the polypeptides are varied at selected positions by incorporating all 20 different amino acids at each position to be varied.
14 . The library according to any one of claims 9 - 12 , wherein the polypeptides are varied at selected positions by incorporating some but not all of the 20 different amino acids at each position to be varied.Join the waitlist — get patent alerts
Track US2003148372A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.